Tetroxoprim

This classification denotes a dihydrofolate reductase inhibitor with the molecular formula C16H22N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5R6712AY0K, chemically known as 2,4-pyrimidinediamine, 5-((3,5-dimethoxy-4-(2-methoxyethoxy)phenyl)methyl)- but more generally known as tetroxoprim, which bears US NIH Compound Identifier 65450. European Medicines Agency schedules Tetroxoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10953MIG. The term TETROXOPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, No. 10 1975, List 15). TETROXOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.